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Background: Human parainﬂuenza viruses account for a signiﬁcant proportion of lower respi-
ratory  tract infections in children.
Objective: To assess the prevalence of Human parainﬂuenza viruses as a cause of acute respi-
ratory infection and to compare clinical data for this infection against those of the human
respiratory syncytial virus.
Methods: A prospective study in children younger than ﬁve years with acute respiratory
infection was conducted. Detection of respiratory viruses in nasopharyngeal aspirate sam-
ples  was performed using the indirect immunoﬂuorescence reaction. Length of hospital
stay,  age, clinical history and physical exam, clinical diagnoses, and evolution (admission
to  Intensive Care Unit or general ward, discharge or death) were assessed. Past personal
(premature birth and cardiopathy) as well as family (smoking and atopy) medical factors
were  also assessed.
Results: A total of 585 patients were included with a median age of 7.9 months and median
hospital stay of six days. No difference between the HRSV+ and HPIV+ groups was found
in  terms of age, gender or length of hospital stay. The HRSV+ group had more fever and
cough. Need for admission to the Intensive Care Unit was similar for both groups but more
deaths were recorded in the HPIV+ group. The occurrence of parainﬂuenza peaked during
the autumn in the ﬁrst two years of the study.
Conclusion: Parainﬂuenza was responsible for signiﬁcant morbidity, proving to be the second-
most prevalent viral agent in this population after respiratory syncytial virus. No differenceon win  clinical presentatiHPIV+ group.
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cute respiratory tract infections (ARTIs) in childhood are
 major cause of morbidity and mortality, with pneumonia
eing the leading cause of death among children between one
nd ﬁve years old.1,2 Viruses are the predominant etiology of
RTIs in this pediatric group.3–5
The human parainﬂuenza viruses (HPIVs) account for a
igniﬁcant proportion of lower respiratory tract infections in
hildren, where their rates of detection vary with pathology
respiratory infection of the upper or lower tract) and with the
nvestigation setting (outpatient units or hospital wards).6
With the attention of parents and medical professionals
rmly focused on annual outbreaks of respiratory syncy-
ial virus (HRSV) and inﬂuenza, HPIV infections can be
verlooked.7 However, HPIVs are the second most common
ause of lower and upper respiratory tract infections in chil-
ren younger than ﬁve years after HRSV.8–11
This prospective study was conducted to determine the
revalence of HPIVs in children hospitalized for ARTI, assess
he clinical characteristics of HPIV+ and HRSV+ patients, and
o compare the two  groups identifying any speciﬁc features of
nfections caused by HPIVs. Seasonality was also examined in
he present study.
ethods
his prospective study included all children with ARTI
ounger than ﬁve years with prodromes of upper respira-
ory tract infections (URTIs) on clinical history, admitted to
he hospital general wards or Intensive Care Unit (ICU) of the
epartment of Pediatrics of Santa Casa de São Paulo Hospital
São Paulo city), between February 2005 and May 2007. After
007, surveillance continued but using other methodology for
iagnosing viral infections. Immunosuppressed patients like
IV-infected, and those with neoplasia or transplantions were
xcluded.
The Central Hospital at Santa Casa de São Paulo is a refer-
nce university hospital for the central and northern region of
he city providing high complexity care, including emergency
are. Approximately 60,000 patients receive medical atten-
ion annually at urgency and emergency units. Out of 9500
dmissions during the study period, around one-third was due
o respiratory infections. Data on clinical characteristics and
emographics were collected at patient admission. The study
as approved by the Research Ethics Committee of the Hos-
ital under the number 064/09. Prior to inclusion in the study,
arents or legal guardians of the patients signed a free and
nformed consent form. ARTI was deﬁned as the presence of
wo or more  signs of inferior respiratory tract involvement:
espiratory dysfunction, characterized by fatigue, tachyp-
ea, wheezing, crackling, and/or fever (axillar temperature
f 37.8 ◦C) on physical exam. The prodromes of URTIs were
haracterized by the presence of coryza, sneezing, and/or
asal obstruction. Disease history was considered in the last
ve days. Bronchiolitis was characterized by ﬁrst episodes of
heezing in infants with URTI prodromes; children with pre-
ious episodes of pulmonary wheezing were diagnosed as5;1 9(4):358–362 359
recurrent wheezing, while acute crisis was characterized as
acute wheezing. Cases with crackles on pulmonary auscul-
tation and lung consolidation on chest radiography exams
were considered alveolar pneumonia, whereas cases with dif-
fuse inﬁltration and with crackling on pulmonary auscultation
were diagnosed as non-alveolar pneumonia.
All patients included in the study had samples of nasopha-
ryngeal secretion collected within the ﬁrst 24 h of admission.
Samples were then stored on ice and sent to the Adolfo Lutz
institute for Indirect Immunoﬂuorescence (IIF), performed
using a panel of ﬁve monoclonal antibodies speciﬁc for HRSV,
Inﬂuenza A and B, HPIV 1, 2 and 3, and Adenovirus, for the
detection of seven viruses (Kit Light Diagnostic TM,  Chemicon
International Inc, Temecula, USA).
Variables analyzed included age, gender, admission date,
clinical characteristics (cough, fever, shortness of breath, and
apnea), data on physical exam (wheezing, dyspnea, cyanosis,
inspiratory nasal wing collapse), clinical diagnoses, personal
(cardiopathy, premature birth, and gastroesophagic reﬂux)
and family (smoking and atopy) medical histories, patient hos-
pital ward (general or ICU), and outcome (discharge or death).
Patients were categorized into two groups (HPIV+ or HRSV+
on IIF) and subsequently compared. Medians of quantitative
variables were compared using the Mann–Whitney test. Qual-
itative variables were analyzed by comparing proportions in
each group using the Chi-square or Fisher’s exact tests as
applicable. The level of signiﬁcance was set at 0.05. All sta-
tistical tests were performed using the Sigma Stat program
version 3.5.
Results
A total of 585 patients were included in the study. HPIVs
were detected in 45 patients, corresponding to 19.9% of all
positive cases, and 7.7% of children overall. The HRSV was
the most frequently detected viral agent (26.5%). IIF was pos-
itive for inﬂuenza in 3.42% of patients and adenovirus in
1%. The clinical data of the HPIV-positive patients was com-
pared against data from HRSV-positive subjects (see Table 1).
A total of 44.4% of HPIV positive patients were female ver-
sus 43.9% in the HRSV-positive group. Median age was similar
among HPIV+ and HRSV groups, 6.8 and 7.1 months, respec-
tively. Length of hospital stay (median six days) was also
similar in the two groups. Comparing signs and symptoms
of acute lower respiratory tract infection between HPIV+ and
HRSV+ groups revealed greater proportion of cough (96.1%
vs 82.2%, p < 0.05) and fever (72.3% vs 48.9%, p < 0.05) in the
HRSV group. No statistically signiﬁcant difference was found
for the other signs and symptoms examined, including short-
ness of breath, wheezing, dyspnea, and cyanosis. The most
frequent diagnoses in the HPIV+ group were acute wheezing
(28.9%), non-alveolar pneumonia associated to acute wheez-
ing (26.7%), and bronchiolitis (22.2%). In the HRSV+ group
diagnoses were bronchiolitis (35.5%), non-alveolar pneumonia
associated with acute wheezing (27.1%), and acute wheezing
(14.5%). Both groups were similar with regard to past personal
medical history of premature birth, congenital cardiopathy,
and gastroesophagic reﬂux disease, as well as for family his-
tory of atopy and smoking (Table 1). Of the patients in the
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Table 1 – Clinical characteristics associated with
infections by human parainﬂuenza viruses (HPIVs) and
respiratory syncytial virus (HRSV) (n = 585).
Clinical characteristics PIVs
(n = 45)
HRSV
(n  = 155)
Female gender 20  (44.4%) 68 (43.9%)
Median age (months) 6.8 7.1
Length of hospital stay (days) 6 6
Signs and symptoms of ARTI
Cough 37 (82.2%) 149 (96.1%)a
Fever 22 (48.9%) 112 (72.3%)b
Shortness of breath 28 (62.2%) 115 (74.2%)
Wheezing 30 (66.7%) 85 (54.8%)
Dyspnea 27 (60%) 96 (61.9%)
Cyanosis 4 (8.9%) 4 (2.58%)
ARTI diagnoses
Acute wheezing 13 (28.9%) 23 (14.5%)
Non-alveolar pneumonia 12 (26.7%) 42 (27.1%)
Bronchiolitis 10 (22.2%) 55 (35.5%)
Personal medical history
Premature birth 6 (13.3%) 13 (8.4%)
Congenital cardiopathy 4 (8.9%) 8 (5.2%)
Gastroesophagic reﬂux 5 (11.1%) 11 (7.1%)
Family medical history
Atopy 20 (44.4%) 56 (36.1%)
Smoking 6 (13.3%) 20 (12.9%)
ICU admission 7 (15.5%) 17 (10.9%)
Death 4 (8.9%) 2 (1.3%)c
a p = 0.0037.
b p = 0.0058.
higher risk for developing severe disease (less than threec p = 0.024.
HRSV+ group, 10.9% were ICU cases compared with 15.5% in
the HPIV+ group (Table 1). A greater number of deaths were
recorded in the HPIV+ group compared with the HRSV+ group
(8.9% vs. 1.29%, p < 0.05) (Table 1).
Of the HPIVs detected, the most frequent type was HPIV-3
(84.4%) followed by HPIV-2 (8.89%) and HPIV-1 (6.67%).
The peak detection rate of the HRSV occurred in the
autumn season during the study period. In the ﬁrst two years
of the study, a higher incidence of HPIVs was observed accom-
panying the HRSV peaks (Fig. 1).
Discussion
The HPIVs are important etiologic agents of acute respi-
ratory infection in childhood and rank second among the
most common diseases in this age group by some authors.
HPIVs predominantly cause lower respiratory tract infection
in infants and young children,12–14 and the signiﬁcance of the
virus has been underappreciated.9
In the present investigation, the prevalence of HPIVs was
7.7%, the second most common virus after HRSV, whose preva-
lence was 26.5%. This result corroborates the ﬁndings of other
studies with similar design.15–17 We  adopted IIF as the method
of viral investigation, as it is a reliable technique with 50–75%
sensitivity and excellent speciﬁcity.12,18 Some authors claim
that molecular methods (PCR and Real-Time PCR) offer 10–20% 1 5;1  9(4):358–362
greater sensitivity for detecting HPIVs over culture and IIF
techniques,19,20 but with higher cost.
Earlier studies have reported higher prevalence of HPIVs
than in the present study but had different study designs and
viral detection methods. For instance, the study by Rihkanen
et al., investigating the etiology of croup in patients attend-
ing emergency services, found HPIVs, particularly type 1, in
29.1% of patients.21 HPIV1 is known to be the main etio-
logic agent of croup, accounting for 56–74% of such cases. A
cohort study conducted in Spain, involving patients hospi-
talized for ARTI aged up to 14 years using PCR as the viral
detection method, showed a 9.9% HPIV prevalence, ranking
third among the most frequent viruses after the HRSV, Rhi-
novirus and Adenovirus.6 In a study aiming to determine the
etiology of community-acquired pneumonia in hospitalized
patients aged younger than ﬁve in Salvador city in northeast-
ern Brazil, HPIVs ranked second among the most prevalent
agents, followed by Rhinovirus.22
The prevalence of HPIV-3 was substantially higher than
HPIV-1 and 2 in this study, whereas HPIV-4 was not stud-
ied. It is known that HPIV-3 is the HPIV type most frequently
detected in hospitalized patients, particularly among young
infants, and associated with the diagnoses of bronchiolitis and
pneumonia.12,23
Other studies have shown HPIV-3 to be the most prevalent
in hospitalized patients, such as the work by Calvo et al.6 in
addition to studies conducted in Brazil by Fe et al.24 assessing
the prevalence of HPIVs in patients up to 16 years old with
ARTI, and the study by Veja-Bricen˜o et al. conducted in Chile.25
Evidence conﬁrms that HPIV-1 is associated with the diagnosis
of croup, but not a single case of croup or laryngitis associated
to croup was found in our study, perhaps because our cases
were often less severe, not requiring hospitalization.
Comparing the clinical data of HPIVs and HRSV infected
groups, we  found no statistically signiﬁcant differences in
terms of hospital stay or need for ICU admission. With regard
to signs and symptoms of ARTI, there were greater proportions
of cough and fever in the HRSV-infected group. Despite this
association, because signs and symptoms were very unspe-
ciﬁc and general, none of these could be attributed to a speciﬁc
agent.25,26
The highest rates of HPIV isolation (detection) occurred
during autumn in the ﬁrst two years of the study, coinciding
with peak incidence of the HRSV. The classic seasonal pattern
of HPIV infection is described in the United States, with bian-
nual peaks of HPIV1 during fall and winter, and annual peaks
of HPIV3, particularly at the end of winter or in spring.9,27 Stud-
ies in tropical countries are scarce, although one investigation
reported seasonal peaks of HPIV3 at the end of winter and in
spring in Rio de Janeiro,28 while other studies carried out in
Northeastern and Southern Brazil both showed peaks during
October, coinciding with spring.24,29
Evidence shows that HPIV infections tend to be less severe
than those caused by HRSV.6 More deaths occurred in children
hospitalized for HPIVs than among HRSV-infected patients.
The deaths occurred in children outside the age group atmonths old), but all these cases had contributing medical
factors, with two having history of premature birth, one recur-
rent wheezing case with gastroesophagic reﬂux, and another
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ith delayed neuro-psychomotor development secondary to
eonatal anoxia and recurrent wheezing. The prevention
trategy of administering immunoglobulin is well established
or HRSV, and studies are underway for vaccines against this
gent. For HPIVs however, viruses with signiﬁcant impact in
erms of morbidity and mortality, no established strategy is
urrently in place.
In conclusion, the impact caused by HPIVs infections is sig-
iﬁcant in hospitalized children, where this agent should be
onsidered as a cause of ARTI. Longitudinal studies determin-
ng the prevalence of respiratory viruses should be encouraged
o help devise prevention and treatment strategies.
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